{"id":"W2983340932","doi":"10.2217/fca-2019-0038","title":"Andexanet Alfa for Reversal of Factor Xa Inhibitors: A Critical Review of the Evidence","year":2019,"lang":"en","type":"review","venue":"Future Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; University Health Network","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Hemostasis; Intensive care medicine; Vitamin k; Pharmacology; Internal medicine; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004963425,0.000262796,0.003551898,0.00007913306,0.00002183598,0.000002385756,0.0002150443,0.000408239,0.00008214817],"category_scores_gemma":[0.002816471,0.0001426702,0.002027108,0.0002160342,0.0001312536,0.00003542097,0.0001272243,0.000236723,0.00001123292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004739453,"about_ca_system_score_gemma":0.0002623337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001374754,"about_ca_topic_score_gemma":2.237622e-7,"domain_scores_codex":[0.9980713,0.0003634103,0.0008426787,0.0003094856,0.0002243873,0.0001888033],"domain_scores_gemma":[0.9971495,0.001433888,0.0004714114,0.0006610187,0.0002381632,0.00004605782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005938248,0.000002123761,0.001013392,0.7104523,0.0007436225,0.00000401306,0.00001500763,1.701343e-7,0.000003807185,0.001097498,0.06770284,0.2189058],"study_design_scores_gemma":[0.0001818905,0.0001416803,0.000188731,0.09977251,0.004053347,0.00003632427,0.000007048082,2.125098e-7,0.000001250216,0.00001052251,0.8954994,0.0001070875],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001596804,0.9908798,0.00006975853,0.002649508,0.003194129,0.002797701,0.0001471002,0.00001148783,0.0002488857],"genre_scores_gemma":[0.00003149266,0.9916791,0.0001587023,0.0002722393,0.007273064,0.00001848656,0.00008392893,0.00002552021,0.0004574264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8277966,"threshold_uncertainty_score":0.5817922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2455988392898778,"score_gpt":0.4509296152278545,"score_spread":0.2053307759379767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}